FOXO1 and myelodysplastic syndrome: The increase in the proportion of S phase cells in MDS-L following knockdown of FOXO1 was not totally reversed by subsequent DAC treatment, suggesting that FOXO1 activation plays an indispensable role in DAC-induced cell cycle arrest (Figure 4E).